seventh Ovarian Cancer Day falling 8 forum ovarian cancer prevention treatment held Tuesday Beijing Health Times health publication affiliated People DailyIndustry figures attending called increased efforts develop domestically produced drugs promotion standardized treatment procedures provide disease care ovarian cancer patients ChinaWu Lingying director gynecological oncology department Cancer Hospital Chinese Academy Medical Sciences ovarian cancer difficult detect 70 percent ovarian cancer patients diagnosed late stages majority patients cancer relapsesAs time windows relapses shorten fiveyear survival rate cancer low adding standardized treatment procedures deliver outcomes patientsLiu Wengui founder Mijian 360com online community cancer patients families lot drugs treatments emerged cancers ovarian cancerMany patients worried medicine shortages relapses saidLiang Yi chief commercial officer China president Zai Lab biopharmaceutical company based Shanghai compared cancers affect populations ovarian cancer receive attention pharmaceutical industry public ChinaHe company devoted bringing treatment Chinese patients fast China National Medical Products Administration earlier accepted company drug application ZEJULA niraparib ZL2306 category drug fasttrack reviewThe drug maintenance treatment adult patients recurrent epithelial ovarian fallopian tube primary peritoneal ovarian cancer complete partial response platinumbased chemotherapySong Ruilin executive president China Pharmaceutical Innovation Development Association Chinese pharmaceutical companies remarkable progress drug development yearsHe hopes innovation Chinese pharmaceutical companies provide drugs Chinese cancer patients cancers affect populations China countries